Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis

A. L. Clos, C. A. Lasagna-Reeves, D. L. Castillo-Carranza, U. Sengupta, G. R. Jackson, Brent Kelly, T. M. Beachkofsky, Rakez Kayed

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background Primary cutaneous nodular amyloidosis (PCNA) is thought to be a plasma cell dyscrasia. The amyloid deposits are found in the dermis and subcutis, and they contain clonal immunoglobulin light chains, produced by a local proliferation of plasma cells. New insights into amyloid diseases have revealed that the pathology is due more to the presence of small, misfolded protein species termed oligomers than to the deposition of fibrillar material. Objectives To demonstrate the presence of amyloid oligomers in PCNA and to provide evidence that cutaneous amyloid diseases share a common pathogenic pathway similar to other amyloid diseases. Methods Immunohistochemical staining with conformation-specific and sequence-specific antibodies was used to localize different amyloid species of light chain immunoglobulins in a case of PCNA. Additionally, in vitro characterization of immunoglobulin oligomers and fibrils was performed to determine, through toxicity studies in a human keratinocyte cell line, which amyloidogenic form of the immunoglobulin is toxic in PCNA. Results Amyloid oligomers were identified in PCNA. Oligomers were mainly formed by lambda light chain immunoglobulins, and kappa light chain oligomers were detected in lesser amounts. Amyloid species were detected intra- and extracellularly. In addition, amyloid oligomers and fibrils, derived from unknown protein sources, were detected. This finding suggests that immunoglobulin amyloids can act as seeds capable of inducing the aggregation of heterogeneous proteins in the skin. Furthermore, cytotoxicity studies demonstrated that immunoglobulin oligomers, but not monomers or fibrils, are toxic to human keratinocytes. Conclusions These data indicate that PCNA has common pathways with other amyloid diseases with respect to protein misfolding and pathogenesis. Immunoglobulin oligomers may prove to be targets for the treatment of PCNA.

Original languageEnglish (US)
Pages (from-to)1349-1354
Number of pages6
JournalBritish Journal of Dermatology
Volume165
Issue number6
DOIs
StatePublished - Dec 2011

Fingerprint

Immunoglobulin Light Chains
Amyloid
Immunoglobulins
Poisons
Keratinocytes
Proteins
Immunoglobulin kappa-Chains
Primary Cutaneous Amyloidosis
Paraproteinemias
Amyloid Plaques
Dermis
Plasma Cells
Skin Diseases
Seeds
Pathology
Staining and Labeling

ASJC Scopus subject areas

  • Dermatology

Cite this

Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis. / Clos, A. L.; Lasagna-Reeves, C. A.; Castillo-Carranza, D. L.; Sengupta, U.; Jackson, G. R.; Kelly, Brent; Beachkofsky, T. M.; Kayed, Rakez.

In: British Journal of Dermatology, Vol. 165, No. 6, 12.2011, p. 1349-1354.

Research output: Contribution to journalArticle

Clos, AL, Lasagna-Reeves, CA, Castillo-Carranza, DL, Sengupta, U, Jackson, GR, Kelly, B, Beachkofsky, TM & Kayed, R 2011, 'Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis', British Journal of Dermatology, vol. 165, no. 6, pp. 1349-1354. https://doi.org/10.1111/j.1365-2133.2011.10508.x
Clos, A. L. ; Lasagna-Reeves, C. A. ; Castillo-Carranza, D. L. ; Sengupta, U. ; Jackson, G. R. ; Kelly, Brent ; Beachkofsky, T. M. ; Kayed, Rakez. / Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis. In: British Journal of Dermatology. 2011 ; Vol. 165, No. 6. pp. 1349-1354.
@article{587a5076d7684a7b98003149c0119cc6,
title = "Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis",
abstract = "Background Primary cutaneous nodular amyloidosis (PCNA) is thought to be a plasma cell dyscrasia. The amyloid deposits are found in the dermis and subcutis, and they contain clonal immunoglobulin light chains, produced by a local proliferation of plasma cells. New insights into amyloid diseases have revealed that the pathology is due more to the presence of small, misfolded protein species termed oligomers than to the deposition of fibrillar material. Objectives To demonstrate the presence of amyloid oligomers in PCNA and to provide evidence that cutaneous amyloid diseases share a common pathogenic pathway similar to other amyloid diseases. Methods Immunohistochemical staining with conformation-specific and sequence-specific antibodies was used to localize different amyloid species of light chain immunoglobulins in a case of PCNA. Additionally, in vitro characterization of immunoglobulin oligomers and fibrils was performed to determine, through toxicity studies in a human keratinocyte cell line, which amyloidogenic form of the immunoglobulin is toxic in PCNA. Results Amyloid oligomers were identified in PCNA. Oligomers were mainly formed by lambda light chain immunoglobulins, and kappa light chain oligomers were detected in lesser amounts. Amyloid species were detected intra- and extracellularly. In addition, amyloid oligomers and fibrils, derived from unknown protein sources, were detected. This finding suggests that immunoglobulin amyloids can act as seeds capable of inducing the aggregation of heterogeneous proteins in the skin. Furthermore, cytotoxicity studies demonstrated that immunoglobulin oligomers, but not monomers or fibrils, are toxic to human keratinocytes. Conclusions These data indicate that PCNA has common pathways with other amyloid diseases with respect to protein misfolding and pathogenesis. Immunoglobulin oligomers may prove to be targets for the treatment of PCNA.",
author = "Clos, {A. L.} and Lasagna-Reeves, {C. A.} and Castillo-Carranza, {D. L.} and U. Sengupta and Jackson, {G. R.} and Brent Kelly and Beachkofsky, {T. M.} and Rakez Kayed",
year = "2011",
month = "12",
doi = "10.1111/j.1365-2133.2011.10508.x",
language = "English (US)",
volume = "165",
pages = "1349--1354",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis

AU - Clos, A. L.

AU - Lasagna-Reeves, C. A.

AU - Castillo-Carranza, D. L.

AU - Sengupta, U.

AU - Jackson, G. R.

AU - Kelly, Brent

AU - Beachkofsky, T. M.

AU - Kayed, Rakez

PY - 2011/12

Y1 - 2011/12

N2 - Background Primary cutaneous nodular amyloidosis (PCNA) is thought to be a plasma cell dyscrasia. The amyloid deposits are found in the dermis and subcutis, and they contain clonal immunoglobulin light chains, produced by a local proliferation of plasma cells. New insights into amyloid diseases have revealed that the pathology is due more to the presence of small, misfolded protein species termed oligomers than to the deposition of fibrillar material. Objectives To demonstrate the presence of amyloid oligomers in PCNA and to provide evidence that cutaneous amyloid diseases share a common pathogenic pathway similar to other amyloid diseases. Methods Immunohistochemical staining with conformation-specific and sequence-specific antibodies was used to localize different amyloid species of light chain immunoglobulins in a case of PCNA. Additionally, in vitro characterization of immunoglobulin oligomers and fibrils was performed to determine, through toxicity studies in a human keratinocyte cell line, which amyloidogenic form of the immunoglobulin is toxic in PCNA. Results Amyloid oligomers were identified in PCNA. Oligomers were mainly formed by lambda light chain immunoglobulins, and kappa light chain oligomers were detected in lesser amounts. Amyloid species were detected intra- and extracellularly. In addition, amyloid oligomers and fibrils, derived from unknown protein sources, were detected. This finding suggests that immunoglobulin amyloids can act as seeds capable of inducing the aggregation of heterogeneous proteins in the skin. Furthermore, cytotoxicity studies demonstrated that immunoglobulin oligomers, but not monomers or fibrils, are toxic to human keratinocytes. Conclusions These data indicate that PCNA has common pathways with other amyloid diseases with respect to protein misfolding and pathogenesis. Immunoglobulin oligomers may prove to be targets for the treatment of PCNA.

AB - Background Primary cutaneous nodular amyloidosis (PCNA) is thought to be a plasma cell dyscrasia. The amyloid deposits are found in the dermis and subcutis, and they contain clonal immunoglobulin light chains, produced by a local proliferation of plasma cells. New insights into amyloid diseases have revealed that the pathology is due more to the presence of small, misfolded protein species termed oligomers than to the deposition of fibrillar material. Objectives To demonstrate the presence of amyloid oligomers in PCNA and to provide evidence that cutaneous amyloid diseases share a common pathogenic pathway similar to other amyloid diseases. Methods Immunohistochemical staining with conformation-specific and sequence-specific antibodies was used to localize different amyloid species of light chain immunoglobulins in a case of PCNA. Additionally, in vitro characterization of immunoglobulin oligomers and fibrils was performed to determine, through toxicity studies in a human keratinocyte cell line, which amyloidogenic form of the immunoglobulin is toxic in PCNA. Results Amyloid oligomers were identified in PCNA. Oligomers were mainly formed by lambda light chain immunoglobulins, and kappa light chain oligomers were detected in lesser amounts. Amyloid species were detected intra- and extracellularly. In addition, amyloid oligomers and fibrils, derived from unknown protein sources, were detected. This finding suggests that immunoglobulin amyloids can act as seeds capable of inducing the aggregation of heterogeneous proteins in the skin. Furthermore, cytotoxicity studies demonstrated that immunoglobulin oligomers, but not monomers or fibrils, are toxic to human keratinocytes. Conclusions These data indicate that PCNA has common pathways with other amyloid diseases with respect to protein misfolding and pathogenesis. Immunoglobulin oligomers may prove to be targets for the treatment of PCNA.

UR - http://www.scopus.com/inward/record.url?scp=82255192409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255192409&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2011.10508.x

DO - 10.1111/j.1365-2133.2011.10508.x

M3 - Article

C2 - 21729025

AN - SCOPUS:82255192409

VL - 165

SP - 1349

EP - 1354

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 6

ER -